IMMEDICA
Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the Middle East. Immedica provides significant know-how and experience from the commercialization of niche/specialty care products across Europe and the Middle East, and the company’s management team has an outstanding track record of operating niche pharma products internationally. Immedica has capabilities to provide optimal access to special... ty care medicines to patients with significant medical needs, including key areas such as regulatory affairs, pharmacovigilance, medical affairs, pricing & reimbursement, quality, and product distribution. Immedica’s main owner is Impilo AB, a private Nordic investment company established in 2017, with more than SEK 3.6 billion in committed capital from leading Nordic and international investors.
IMMEDICA
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2018-05-02
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.immedica.com
Total Employee:
51+
Status:
Active
Contact:
+46(0)8 533 39 500
Email Addresses:
[email protected]
Similar Organizations
A-apoteket
A-apoteket is a pharmacy store chain in Denmark that offers medicine and health care products.
Farmak
Farmak is a pharmaceutical company that creates and manufactures medical drugs.
GustoPharma Consumer Health
GustoPharma Consumer Health is a pharmaceutical company specialized in health care products.
Current Advisors List
Current Employees Featured
Official Site Inspections
http://www.immedica.com
- Host name: ec2-52-17-142-199.eu-west-1.compute.amazonaws.com
- IP address: 52.17.142.199
- Location: Dublin Ireland
- Latitude: 53.3338
- Longitude: -6.2488
- Timezone: Europe/Dublin
- Postal: D02
More informations about "Immedica"
Sustainable organization and operations - Immedica
Immedica’s employees are our most important assets for a successful and sustainable business. An employee satisfaction survey is executed on a yearly basis to capture any deviations that …See details»
About us - Immedica
Immedica was founded in 2018. By that time we were 7 employees and had a turnover of SEK 85 M. Now we are more than 140 employees with a turnover above SEK 1 billion. Our two main …See details»
Sustainability | Immedica
For us, sustainability encompasses empowering our employees, fostering a positive work environment at Immedica, cultivating sustainable partnerships, and establishing a socially and …See details»
About us | Immedica
Immedica was founded in 2018 by the investment company Impilio and Buy-in-Management. We started with 7 employees and an initial turnover of SEK 85 M. 90+ Employees today, across …See details»
Immedica - Crunchbase Company Profile & Funding
Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the Middle East. Immedica …See details»
Immedica Pharma AB - The Org
About Immedica Pharma Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the …See details»
Immedica Pharma AB - Leadership Team - The Org
The Leadership Team at Immedica Pharma AB is responsible for steering the company's strategic direction, overseeing commercial operations, and managing financial performance. Comprised …See details»
Immedica Pharma AB, Financial Info, Board and Management, …
Newsletter. (c) Pateleon AB 2020 All Rights ReservedSee details»
Immedica - Impilo
Currently, Immedica distributes a portfolio of c. 25 drugs, spanning proprietary, in-licensed and partnered products with a focus on genetic and metabolic diseases, oncology, and …See details»
Immedica - Products, Competitors, Financials, Employees, …
Prior to joining Immedica, Benjamin served as Chief Business Officer and a Board Member at Peptone, where he was instrumental in pivoting the company’s strategy to therapeutics …See details»
Chicago Becomes U.S. Base for Global Rare Disease Company
Sep 9, 2024 John Conrad, President and CEO of iBIO (Illinois Biotechnology Innovation Organization), welcomed Immedica’s decision to establish its U.S. operations in Chicago: …See details»
We are Immedica! | Immedica
Immedica’s most valuable assets are our employees. To have a healthy work environment, motivating job tasks, possibility to develop, have pride in the work we do, have fun and enjoy …See details»
KKR Acquires Immedica Pharma, Spearheading Rare Disease …
Apr 23, 2024 “I am excited to continue our partnership with Impilo and welcome KKR as a new strategic partner for the next step in Immedica’s journey,” said Anders Edvell, CEO of …See details»
Immedica - Overview, News & Similar companies | ZoomInfo.com
Apr 23, 2024 Who is Immedica. Immedica is a fast-growing private niche pharma group with its headquarter in Stockholm, Sweden, and commercial coverage across Europe and the Midd le …See details»
Immedica Pharma AB Information - RocketReach
About Immedica Pharma Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the …See details»
Immedica Pharma AB - Drug pipelines, Patents, Clinical trials
Explore Immedica Pharma AB with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 27 news, and 1 literature, Disease Domain:Nervous System Diseases, …See details»
Immedica - EU-Startups
Immedica is a fast-growing private niche pharma group. Its headquarter is based in Stockholm, Sweden, and it has commercial coverage across Europe and the Middle East. Immedica …See details»
Contact - Immedica
Get in contact with our various teams across the globe. Find contact details here.See details»
Press releases - Immedica
Sep 20, 2024 Immedica publishes key study on societal impact of ARG1-D. 2024-09-24 09:45. Joe Whalen joins Immedica's Business development team. 2024-09-20 08:00. Joint …See details»
Therapeutic areas - Immedica
Immedica works within three therapeutic areas which are Genetic & Metabolic diseases, Hematology & Oncology, and Specialty Care.See details»